Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas-Reference-Cited by-同舟云学术

Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas

Published:2012-02-28 Issue:2 Volume:7 Page:e30313
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Puget Stephanie,Philippe Cathy,Bax Dorine A.,Job Bastien,Varlet Pascale,Junier Marie-Pierre,Andreiuolo Felipe,Carvalho Dina,Reis Ricardo,Guerrini-Rousseau Lea,Roujeau Thomas,Dessen Philippe,Richon Catherine,Lazar Vladimir,Le Teuff Gwenael,Sainte-Rose Christian,Geoerger Birgit,Vassal Gilles,Jones Chris,Grill Jacques

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference79 articles.

1. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database.;I Qaddoumi;Cancer,2009

2. Diffuse brainstem glioma in children: critical review of clinical trials.;D Hargrave;The lancet oncology,2006

3. Advances toward an understanding of brainstem gliomas.;SS Donaldson;J Clin Oncol,2006

4. Small molecule inhibitors in children with malignant gliomas.;B Herrington;Pediatr Blood Cancer,2009

5. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.;R Jalali;Int J Radiat Oncol Biol Phys,2010

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and Biological Concepts in Pediatric High-Grade Gliomas;Cells;2024-09-05

2. H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition;2024-08-27

3. Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma;Journal of Controlled Release;2024-06

4. Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies;Cancer Letters;2024-05

5. Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors;Critical Reviews in Oncology/Hematology;2023-12